NEW YORK (GenomeWeb News) – Waters today said that revenues for the second quarter inched up 1 percent, as the firm missed analyst estimates on the top line.

For the three months ended June 30, the firm posted revenues of $451.5 million, up just under 1 percent from $447.6 million for the second quarter of 2011, but missing Wall Street expectations of $458.4 million. Its organic growth for the quarter was 4 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.